Balasa Dinverno & Foltz’s Thermo Fisher Scientific TMO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2022
Q3
$1.73M Buy
3,402
+246
+8% +$125K 0.11% 76
2022
Q2
$1.72M Buy
3,156
+269
+9% +$146K 0.11% 77
2022
Q1
$1.71M Sell
2,887
-252
-8% -$149K 0.12% 82
2021
Q4
$2.09M Buy
3,139
+210
+7% +$140K 0.13% 71
2021
Q3
$1.67M Buy
2,929
+118
+4% +$67.4K 0.12% 87
2021
Q2
$1.42M Sell
2,811
-254
-8% -$128K 0.1% 98
2021
Q1
$1.4M Buy
3,065
+1
+0% +$456 0.11% 90
2020
Q4
$1.43M Buy
3,064
+971
+46% +$452K 0.12% 84
2020
Q3
$924K Sell
2,093
-7
-0.3% -$3.09K 0.09% 99
2020
Q2
$761K Sell
2,100
-55
-3% -$19.9K 0.08% 101
2020
Q1
$611K Sell
2,155
-162
-7% -$45.9K 0.08% 119
2019
Q4
$753K Buy
2,317
+18
+0.8% +$5.85K 0.08% 117
2019
Q3
$670K Buy
2,299
+32
+1% +$9.33K 0.08% 122
2019
Q2
$666K Buy
2,267
+23
+1% +$6.76K 0.08% 117
2019
Q1
$614K Buy
2,244
+6
+0.3% +$1.64K 0.07% 114
2018
Q4
$501K Buy
2,238
+46
+2% +$10.3K 0.06% 126
2018
Q3
$535K Buy
2,192
+31
+1% +$7.57K 0.06% 132
2018
Q2
$448K Buy
2,161
+22
+1% +$4.56K 0.06% 136
2018
Q1
$442K Sell
2,139
-102
-5% -$21.1K 0.07% 133
2017
Q4
$426K Sell
2,241
-18
-0.8% -$3.42K 0.06% 132
2017
Q3
$427K Buy
2,259
+132
+6% +$25K 0.07% 131
2017
Q2
$371K Sell
2,127
-4
-0.2% -$698 0.06% 144
2017
Q1
$327K Sell
2,131
-15
-0.7% -$2.3K 0.06% 146
2016
Q4
$303K Sell
2,146
-93
-4% -$13.1K 0.05% 143
2016
Q3
$356K Sell
2,239
-90
-4% -$14.3K 0.07% 122
2016
Q2
$344K Buy
2,329
+164
+8% +$24.2K 0.06% 124
2016
Q1
$307K Buy
2,165
+84
+4% +$11.9K 0.05% 132
2015
Q4
$295K Buy
2,081
+33
+2% +$4.68K 0.05% 156
2015
Q3
$250K Buy
2,048
+72
+4% +$8.79K 0.04% 164
2015
Q2
$256K Sell
1,976
-40
-2% -$5.18K 0.04% 165
2015
Q1
$271K Sell
2,016
-128
-6% -$17.2K 0.04% 157
2014
Q4
$269K Sell
2,144
-62
-3% -$7.78K 0.04% 156
2014
Q3
$268K Buy
2,206
+96
+5% +$11.7K 0.04% 142
2014
Q2
$249K Buy
2,110
+356
+20% +$42K 0.03% 153
2014
Q1
$211K Buy
+1,754
New +$211K 0.03% 159